{
    "clinical_study": {
        "@rank": "99141", 
        "acronym": "CLINPRADIA", 
        "biospec_descr": {
            "textblock": "urine whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Multicenter stepped wedge cluster randomized trial of family practice clinics in Quebec and\n      Ontario comparing the effect of introducing a Point of Care testing (POCT) for urine albumin\n      to usual practice on quality of care in hypertensive patients with Type 2 diabetes."
        }, 
        "brief_title": "Management of Albuminuria in Hypertensive Diabetics", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Microalbuminuria", 
            "Hypertension", 
            "Type 2 Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Hypertension", 
                "Albuminuria"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female 18 years and older and able to visit the study sites every 3 months\n\n          -  T2D patients with ongoing anti-diabetic therapy for at least 5 years\n\n          -  Uncontrolled hypertension according to 2012 CHEP recommendations for management of\n             hypertension in diabetic patients ( i.e. BP> 130/80 mmHg)\n\n          -  Able and agreeing to provide informed consent.\n\n        Exclusion Criteria:\n\n          -  Type 1 diabetes patients\n\n          -  Ongoing therapy with perindopril,\n\n          -  Known hypersensitivity or allergies to ACEI or  sulfonamide derivatives,\n\n          -  A history of angioedema related or not to previous treatment with ACEI,\n\n          -  Impaired renal function defined as serum creatinine levels > 177 \u00b5mol/L, eGFR  <30\n             mL/min,\n\n          -  Hyperkalemia or hypokalemia,\n\n          -  Severe hepatic impairment,\n\n          -  Use of non-antiarrhythmic agents causing torsade de pointes,\n\n          -  Pregnant or lactating women, or who are planning to become pregnant,\n\n          -  Any conditions which may impact on participation according to treating physician."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "18 years and older Uncontrolled blood pressure Type 2 diabetes"
            }
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01907958", 
            "org_study_id": "CLINPRADIA"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Microalbuminuria", 
            "Hypertensive", 
            "Diabetics", 
            "urine albumin"
        ], 
        "lastchanged_date": "July 24, 2013", 
        "location": {
            "contact": {
                "email": "m-r.guertin@medpharmgene.ca", 
                "last_name": "Marie-Ren\u00e9e Guertin, Project manager", 
                "phone": "514 249 4209", 
                "phone_ext": "222"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H1Y 3L1"
                }, 
                "name": "Medpharmgene"
            }, 
            "investigator": {
                "last_name": "Pavel Hamet", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multicentre Study to Evaluate the Management of Microalbuminuria in Hypertensive Patients With Type 2 Diabetes: Improving Clinical Practice", 
        "other_outcome": {
            "measure": "Demographics, medical history and medication Diabetes and hypertension status Blood pressure measurements", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "overall_contact": {
            "email": "m-r.guertin@medpharmgene.ca", 
            "last_name": "Marie-Ren\u00e9e GUERTIN, project manager", 
            "phone": "514 249 4209", 
            "phone_ext": "222"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Stabilisation or improvement of urine albumin excretion status by at least one stage", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01907958"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Microalbuminuria (or further stages of CKD) after 12 months", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Medpharmgene, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medpharmgene, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Months", 
        "verification_date": "July 2013"
    }
}